ArticleBritish journal of cancer2026

Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study.

Shui-Qing He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.